Iovance Biotherapeutics, Inc. (IOVA) vs Praxis Precision Medicines, Inc. (PRAX)
- Iovance Biotherapeutics, Inc. IOVA 13.58 −7.74%
- Praxis Precision Medicines, Inc. PRAX 241.76 −2.61%
Iovance Biotherapeutics, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. and Praxis Precision Medicines, Inc. are of similar size ($6.9B and $6.7B). Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 34.6%. Praxis Precision Medicines, Inc. has the higher net margin (0.00% vs −89.1%) and the higher return on invested capital (−40.6% vs −43.0%). Across the 16 metrics below, Praxis Precision Medicines, Inc. leads on 11 and Iovance Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | IOVA | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.40% | 100.00% | 65.16% |
| Operating margin | (92.72%) | 0.00% | 0.00% |
| Net margin | (89.09%) | 0.00% | 0.00% |
| Free cash flow margin | (91.21%) | 0.00% | 0.00% |
| Return on equity | (40.36%) | (38.86%) | (56.36%) |
| Return on assets | (31.76%) | (36.80%) | (48.04%) |
| Return on invested capital | (42.96%) | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack